Key Benefits:
Law 14/2011, of June 1, of Science, Technology and Innovation, classifies various organisms and among them the Carlos III Health Institute as a public research body.
Article 61 of Law 50/1998, of 30 December, of Fiscal, Administrative and Social Order Measures, provides that public research bodies shall adopt the configuration of an autonomous body established in the Article 43 (1) (a) of Law 6/1997, of 14 April, of the Organization and the Functioning of the General Administration of the State, with certain peculiarities in the field of personnel, economic resources, budgetary, financial and financial accounting, intervention and financial control.
By Royal Decree 345/2012 of 10 February, which develops the basic organic structure of the Ministry of Economy and Competitiveness, the Carlos III Health Institute is attached to this department, through the Secretary of State for Research, Development and Innovation.
The Carlos III Health Institute is providing certain public services related to its functions through the national centers that are part of its organic structure.
The Carlos III Health Institute, in the provision of services, the supply of goods and the performance of activities, in accordance with the rules invoked, may establish public prices as a financial consideration for such services. activities in the terms laid down in Law 8/1989 of 13 April of Fees and Public Prices, since the services provided by this body present the characteristics required by that Law for the financial compensation to be paid they satisfy themselves for the consideration of public prices at the time at the same time, the two criteria which make it up, that is, pecuniary contracts which are satisfied by the supply of goods, services or activities carried out under public law, where they are not (a) compulsory receipt by the administered authorities, and that such supplies, services or activities are likely to be provided or carried out effectively by the private sector, in the absence of the public sector reserve in accordance with the rules in force.
This activity was regulated so far in the Resolution of 22 March 2013 by the Carlos III Health Institute ("BOE" n. 82 of 5 April 2013) laying down public prices for the provision of services and services. activities of the body.
This resolution modifies public prices for the provision of services and the performance of activities with a dual purpose:
First, it is necessary to update the catalogue of services provided, since during the period since its publication certain demands for services that were not covered by the regulation have been created. in force, while the demand for other benefits that were regulated has been disappearing.
Second, it is necessary to update the amounts of the prices in force for the purpose of adjusting them to cover the costs of the services provided, in compliance with the provisions of Article 25 of Law 8/1989, of 13 April, for Public Fees and Prices.
In view of the above and in view of the diversity of changes to be made, it has been considered appropriate to bring together the changes required by the subject matter in a new resolution allowing for greater clarity and ease of application, unifying criteria and taking into account the characteristics of the services offered from the body.
In its virtue, and as provided for in Article 26.1.b) of Law 8/1989, of 13 April, and in accordance with the jurisdiction conferred by it by Article 13.2 of Order ECC/1695/2012 of 27 July 2012, competencies, this Address resolves:
First.
Set the amount of public prices to be collected by the public research body Carlos III Health Institute for the provision of services or for the performance of activities, included in the Annex, that are carried out under public law by the National Center for Microbiology.
Second.
Access to the standard application for the performance of the services listed in the Annex will be made through the website https://cnm-laboratorios.isciii.es
Users must be identified by authorization granted by the National Center for Microbiology, consisting of a personal key that will be provided upon request.
Third.
Regardless of the prices listed in the Annex, services of a special nature or of a special strategic interest shall be provided at no cost, in the following cases:
a) Studies of outbreaks or cases of any infectious etiology that are of particular alarm or concern from the point of view of health, provided that they are requested, in a reasoned manner, through the health authorities state or autonomous communities.
(b) National, European or international surveillance programmes where infectious agents are required to be confirmed and/or characterised in a reference laboratory. The pathogens included in these programs will be identified in the telematics application of the services portfolio of the National Center for Microbiology of the Health Institute Carlos III.
Fourth.
The payment of the public prices will be made by the income of its amount in the account that the agency has authorized to the effect in the Banco de España with IBAN ES45 9000.0001.20.0200009118.
Single repeal provision.
The Resolution of March 22, 2013, of the Carlos III Health Institute, which establishes public prices for the provision of services and activities of the agency, is repealed.
Single end disposition.
This Resolution shall enter into force within thirty working days after its publication in the "Official State Gazette".
Madrid, June 12, 2015. -Director of the Carlos III Health Institute, Jesús Fernández Crespo.
ANNEX
| agent | Pathogen (analytic method) | Price without VAT |
|||
|---|---|---|---|---|---|
| Bacteria. | IgM/IgG (IFI) anaplasma (IFI). | 46.30 | |||
|
Bacteria. | Anaplasm/Ehrlichia (PCR-hybridization) |
38.10 | |||
|
Bacteria. | Antibiotics (molecular epidemiology). | 27.90 | |||
| Bacteria. | Antibiotics (Identification) | 10.90 |
|||
|
Bacteria. | Antibiotics (phenotypic characterization of resistance mechanisms). | 15.75 | |||
|
Bacteria. | Antibiotics (genotypic characterization of resistance mechanisms). | 19.40 | |||
|
Bacteria. | Antibiotics (antibiotic sensitivity determination). | 39.40 | |||
|
Bacteria. | Bacillus anthracis (real-time PCR). | 44.90 | |||
|
| Gram negative bacteria (molecular characterization). | 66.70 | |||
| Bartonella (characterization) | Bartonella (characterization) | 120,50 | |||
| Bacteria. | Bartonella (PCR-hybridization) | 38.10 |
|||
| Bacteria. | Bartonella IgM/IgG (IFI). | 34.20 | |||
| Bacteria. | Bordetella pertussis Ac (ELISA). | 21.75 | |||
| Bordetella pertussis (characterization) | 98.20 | ||||
|
Bacteria. | Bordetella pertussis (PCR). | 42.40 | |||
| Bacteria. | Borrelia (PCR-hybridization). | 38.10 | |||
|
Bacteria. | Borrelia burgdorferi (ELISA IgG/ELISA IgM/WB). | 30,50 | |||
| Bacteria. | Brachyspira spp. (PCR-hybridization). | 38.10 | |||
|
Bacteria. | Brucella sp. (real-time PCR). | 44.90 | |||
|
Bacteria. | Burkholderia pseudomallei (IFI). |
17.50 | |||
|
Bacteria. | Burkholderia sp. (PCR-hybridization). | 38.10 | |||
| Bacteria. | Campylobacter (genotypic characterization). | 35.20 | |||
|
Bacteria. |
42.40 | ||||
|
Bacteria. | Table_table_izq"> Campylobacter (identification). | ||||
|
Chlamydia (FC). | 10.30 | ||||
| Bacteria. |
Chlamydia IgG (IFI). | 5.10 | |||
|
Bacteria. | Chlamydia IgM (IFI). | ||||
|
Chlamydia trachomatis Ag (IFD). | 15.75 | ||||
| Bacteria. | Clostridium botulinum (characterization). | 182.00 | |||
|
Bacteria. | Clostridium tetani IgG (ELISA). | 9.50 |
|||
| Bacteria. | Corynebacterium (phenotypic characterization). | 53.40 | |||
| Corynebacterium (genotypic characterization) | 35.20 | ||||
| Corynebacterium (identification) | Corynebacterium (identification) | 17,00 | |||
| Corynebacterium diphteriae IgG (ELISA) | 9.50 | ||||
|
Bacteria. | Coxiella burnetii (real-time PCR). | 44.90 | |||
| Bacteria. | Coxiella burnetti (FC). | 10.30 | |||
|
Bacteria. | Coxiella burnetti, acute phase (IFI). | 10.40 | |||
| Coxiella burnetti, chronic phase (IFI) | 12.80 | ||||
|
Bacteria. | Escherichia coli (phenotypic characterization). | 42.40 | |||
|
Bacteria. | Escherichia coli (characterization genotypic) | 54.60 | |||
| Bacteria. | Escherichia coli (phenotypic determination of mechanisms of resistors). | ||||
|
Bacteria. | Escherichia coli (genotypic determination of resistance mechanisms). | 35.20 | |||
|
Bacteria. | Escherichia coli (isolation and identification). | 44.90 | |||
|
Bacteria. | Escherichia coli (determination of Antibiotic sensitivity) | ||||
|
Bacteria. | Negative coagulase staph (molecular characterization). | 72.75 | |||
|
Bacteria. | Francisella turalensis (PCR-hybridization). | 38.10 | |||
|
| |||||
| 5.00 | |||||
| 5.00 | |||||
| 5.00 | |||||
| 5.00 | |||||
| 5.00 | |||||
| Haemophilus influenzae (antibiotic sensitivity determination) | 55.20 | ||||
| Haemophilus influenzae (identification) | Haemophilus influenzae (identification). | 37.60 | |||
|
Bacteria. | Legionella (characterization). |
Bacteria | |||
|
Legionella (detection and identification) |
| 143.10 | |||
| Legionella pneumophila SG1 Ac (IFI). | 7.00 | ||||
|
Bacteria. | Legionella pneumophila SG1 IgM (IFI). | 7.60 | |||
|
Bacteria. | Leptospira (ELISA IgM/microagglutination). | 31.10 | |||
| The_table_table_izq"> Leptospira sp. (real-time PCR). | 44.90 | ||||
|
Bacteria. | Listeria sp. (characterization). |
74.00 | |||
|
Bacteria. | Bacterial meningitis (PCR-multiplex). | 141.90 | |||
|
| 87.30 | ||||
| Bacteria. |
87,30 | The_table_table_izq"> Mycobacterium tuberculosis complex (resistance gene study). | 34.00 | ||
|
Bacteria. | Mycobacterium tuberculosis complex (genotypic and phenotypic identification). | 31.50 | |||
| Bacteria. | Mycobacterium tuberculosis complex (sensitivity. Bactec 960 MGIT) | 23.00 | |||
|
Bacteria. | Mycobacterium tuberculosis complex (sensitivity. Proportions method). | 19.40 | |||
|
Bacteria. | Mycoplasma pneumoniae IgG (ELISA). | 7.70 | |||
|
Bacteria. | Mycoplasma pneumoniae IgM (ELISA). | 7.70 | |||
| The_table_table_izq"> Neisseria gonorrhoeae (characterization). | 80.00 | ||||
| Bacteria. | Neisseria meningitidis (bactericidal activity). | 100.60 | |||
| Bacteria. | Neisseria meningitidis (characterization). | 154.00 | |||
|
Neisseria sp. identification) | 17.00 | ||||
| Bacteria. | Rickettsia conorii Ac (IFI). | 7.00 | |||
|
Bacteria. | Rickettsia conorii IgM (IFI). | ||||
|
Rickettsia sp. | 38.10 | ||||
| Bacteria. | Salmonella (phenotypic characterization). | 37.60 | |||
| Bacteria. | Salmonella (genotypic characterization). | 103,10 | |||
| Salmonella (antibiotic sensitivity determination) | 17,00 | ||||
| Salmonella (phenotypic determination of resistance mechanisms). | 17,00 | ||||
| Zant_table_izq"> Salmonella (genotypic determination of resistance mechanisms). | 35.20 | ||||
|
Bacteria. |
15.80 | ||||
| Baccteries. | Shigella (phenotypic characterization). | 32.75 | |||
| Shigella (genotypic characterization) | 103.10 | ||||
|
Shigella (phenotypic determination of resistance mechanisms). | 17,00 | ||||
| 35.20 | |||||
|
Bacteria. | Shigella (identification). |
24,25 | |||
| Bacteria. | Shigella (antibiotic sensitivity determination). | 17,00 | |||
| The_table_table_izq"> Staphylococcus aureus (molecular characterization). | 103.00 | ||||
| Bacteria. | Staphylococcus aureus; PVL, SST, and TSST (PCR) toxins. | 60.60 | |||
|
Bacteria. | Streptococcus pneumoniae (characterization). | 57.00 | |||
| Bacteria. | Streptococcus pyogenes (characterization). | 109.10 | |||
|
Bacteria. | bacterial Taxonomy (characterization). | 121.30 | |||
|
Bacteria. | Treponema pallidum (FTA-lcr). | 11.20 | |||
| Treponema pallidum (PCR-hybridization) | 38.10 | ||||
|
Bacteria. | Treponema pallidum (RPR/TPHA/FTA). | 31.60 | |||
| Bacteria. | Treponema pallidum Ac (TPHA-confirmatory). | 8.00 | |||
|
Bacteria. | Treponema pallidum IgM (ELISA). |
16.80 | |||
|
Bacteria. | Trotheryma whipplei (electron microscopy: ultramicrotomy). | 92.90 | |||
|
Trotheryma whipplei (PCR-hybridization). | 38.10 | ||||
|
Bacteria. |
17.00 | ||||
|
Baccteries. | Vibrio sp (genotypic characterization). | 35.20 | |||
| Bacteria. | Vibrio sp (identification) | 24,25 | |||
| Bacteria. | Yersinia (phenotypic characterization). | 35.20 | |||
|
Bacteria. | Yersinia (genotypic characterization). | 103.10 | |||
|
Bacteria. | Yersinia (phenotypic determination of resistance mechanisms). | 17.00 | |||
|
Bacteria. | Yersinia (genotypic determination of resistance mechanisms). | 35.20 |
|||
| Bacteria. | Yersinia (identification). | 35.20 | |||
|
Bacteria. | Yersinia (sensitivity determination Antibiotic). | ||||
|
Bacteria. | Yersinia pestis (PCR-hybridization). | 38.10 | |||
| The_table_table_izq"> Aspergillus spp. (PCR-multiplex). | 135.10 | ||||
| Hongos. | Candida spp. (PCR-multiplex). | 135.10 | |||
|
Hongos. | Cryptococcus neoformans/gattii (genotyping/serotyping). | 122.75 | |||
|
Hongos. | Histoplasma capsulatum (PCR). | 135.70 | |||
|
Hongos. |
98.30 | ||||
| Hongos. | Hongos. Filamentos (identification and sensitivity). | 169,50 | |||
|
Hongos. | Filamentous Honours (identification). | 125.00 | |||
| Itraconazole and hydroxy-itraconazole (quantification) | 91.10 | ||||
|
Hongos. | Levatures (identification and sensitivity). | 123.20 | |||
| Hongos. | Levings (identification) | 86.80 | |||
|
Hongos. | fungal Pneumonia (PCR-multiplex). | 122.75 | |||
|
Hongos. | Panfungium (PCR). | 115.00 | |||
| Paracoccidiodes brasiliensis (PCR) | Paracoccidiodes brasiliensis (PCR) | 115,00 | |||
| Hongos. | Posaconazole (quantification) | 91.10 |
|||
| Hongos. | Scedosporium apiospermum (PCR). | 115.00 | |||
| Scedosporium prolific (PCR) | Scedosporium prolifers. | 115.00 | |||
| Hongos. | Voriconazole (quantification) | 91.10 |
|||
| Hongos. | Zigomicetos (multiplex PCR). | 122.75 | |||
| Immunology. | Determination HLA-DQ2/DQ8 (Celiaquia). | 47.50 | |||
| Immunology. | Determination HFE C282Y (Hemochromatosis). | 37.80 | |||
| Immunology. | HFE H63D Determination (Hemocromatosis). | 37.80 | |||
| Determination HFE S65C (Hemocromatosis). | 37.80 | ||||
| Immunology. |
| 31.80 | |||
| Immunology. |
| 36.60 | |||
| Immunology. | Determination HLA-DQB1*06:02:01G (Narcolepsy). |
36.60 | |||
|
parasites. | Acanthamoeba spp. (cultivation). | 35.00 | |||
|
parasites. | Acanthamoeba spp. (PCR) | 70.10 | |||
|
parasites. | Anisakis (PCR-RFLP). | 57.75 | |||
| . | Anisakis IgE (ELISA; rAni s1/s7 ). | 35.20 | |||
| parasites. | arthropods (Identification). | 155.80 | |||
|
parasites. | arthropods (ingested blood; PCR). |
146,10 | |||
|
parasites. | Babesia sp (characterization). | 151.60 | |||
|
parasites. |
102.00 | ||||
| 102.00 | 102,00 | 51.50 |
parasites. | ||
| Echinococcus granulosus IgG, IgG1, IgG4 (ELISA). | |||||
|
| Echinococcus granulosus/E. Multilocularis (PCR) | 68.00 | |||
|
parasites. | entamoeba histolytica IgG (ELISA). |
19.40 | |||
|
parasites. | entamoeba histolytica/E. disparate (actual PCR-time). | 60.60 | |||
|
Parasites. | Ac hepatic fasciola (ELISA-MM3). |
18.20 | |||
|
parasites. | Filarias (PCR). | 53.50 |
|||
|
parasites. | Giardia (Characterization). | 101.90 | |||
|
Parasites. | Giardia (actual PCR-time). | 54.00 | |||
| parasites. | Giardia and Cryptosporidium Ag (IFD) | 51.00 | |||
|
parasites. |
83.40 | ||||
|
|
20.60 | ||||
|
Leishmania (ICT rK39) |
20.60 |
| 15.75 | ||
| parasites. |
38.20 | ||||
|
Parasites. | Leishmania (xenodiagnosis). | 287.40 | |||
| parasites. | Leishmania in arthropod (isolation and characterization). | 209.80 | |||
|
134.00 | |||||
| 134.00 | 134.00 | 134.00 |
. | Leishmania IgG (IFI). | |
|
parasites. | Onchocerca (PCR). | 57.10 | |||
|
| Onchocerca IgG, IgG1, IgG2, IgG3, IgG4 (ELISA). | 20.60 | |||
|
| Intestinal Parasites (microscopic identification). | 66.70 | |||
|
| Plasmodium (antigen detection) | 19.40 | |||
| parasites. | Plasmodium (PCR-quantitative tracking) | 42.70 | |||
| parasites. | Plasmodium (PCR-multiplex) | 53.20 |
|||
|
parasites. | Plasmodium falciparum (resistors). | 418.40 | |||
|
parasites. | Plasmodium falciparum IgG (IFI). | 20,00 | |||
| parasites. | Plasmodium spp. (ELISA). | 18.20 | |||
|
parasites. | Schistosoma IgG (ELISA). | 19.40 | |||
| parasites. | Strongyloides (actual PCR-time) | 38.80 | |||
|
parasites. | Strongyloides IgG (ELISA). | 15.75 | |||
|
parasites. | Taenia saginata/T. solium (PCR). | 52.70 | |||
|
parasites. | Taenia solium (PCR HDP2-seminested). |
63.80 | |||
|
parasites. | Taenia solium Ag (ELISA). | 17.00 |
|||
|
parasites. | Taenia solium IgG (ELISA). | 19.40 | |||
|
parasites. | Taenia solium IgG (ELISA-FV). | 14,60 | |||
|
parasites. | IgG Toxocara (ELISA) | 19.40 | |||
| parasites. | Toxoplasma gondii (Characterization). | 102.00 | |||
|
Parasites. | Toxoplasma gondii (PCR-nested and PCRc). |
70.30 | |||
|
parasites. | Toxoplasma gondii (Western-Blot). | 106.70 | |||
|
parasites. |
| 20.60 | |||
| Parasites. | Toxoplasma gondii IgG (ELISA; avidity). | 30,30 | |||
| parasites. | Toxoplasma gondii IgM (ELFA). | 21.80 | |||
| Trichinella (chlorhydropepsica digestion). | 59.40 | ||||
|
parasites. |
59.40 | ||||
|
(IFI) | |||||
|
parasites. | Trichinella spp (PCR-multiplex). | 52.10 | |||
|
parasites. |
42.70 | ||||
|
Parasites. | Trypanosoma brucei Ac (agglutination) | 9.70 | |||
|
83.40 | 83.40 | ||||
|
20.60 | |||||
| Parasites. |
20.60 |
| Trypanosoma cruzi (PCR). | 32.10 |
|
| parasites. | trypanosoma cruzi IgG (recombinant ELISA). | 13.30 | |||
|
13.30 | |||||
| 13.30 |
Parasites. | trypanosoma cruzi IgG (ELISA) | |||
| Trypanosoma cruzi IgG (IFI). | 20,00 | ||||
|
parasites. | Wuchereria/Brugia IgG, IgG1, IgG2, IgG3, IgG4 (ELISA) | 20.60 | |||
| Virus. | Adenovirus (FC) | 10.30 | |||
| Virus. | Adenovirus (genotyping). | 151,60 | |||
| Adenovirus (PCR) | 44.10 | ||||
| Virus. | enteric adenovirus (PCR). | ||||
|
. | Alphavirus (PCR). | 101.25 | |||
|
Virus. | Arenavirus (PCR). | 113.40 | |||
|
Virus. | Astrovirus (characterization) | 89,10 | |||
|
Virus. |
Astrovirus (RT-PCR). | 57.60 | |||
| Virus. | Bunyavirus group Encefalitis group (PCR) | 101.25 | |||
|
27.70 | |||||
|
27.70 | |||||
|
| IgG cytomegalovirus (ELISA; avidity). | 21.60 |
|||
| Virus. | Citomegalovirus IgM (ELISA). | 27.70 | |||
| Virus. | Citomegalovirus and Epstein-Barr Virus (multiplex real time PCR). | 41.10 | |||
| Virus. | MERS Coronavirus (PCR). | 58.60 | |||
| Virus. | Entero-Herpesvirus neurotropes (real-time RT-PCR). | 28.10 | |||
| Virus. | Enterovirus (isolation) | 63.70 | |||
| Virus. | Enterovirus (genotyping). |
59.40 | |||
|
. | Enterovirus (RT-PCR; 5NCR region). | 40.00 | |||
| Virus. | Enterovirus (serotyped) | 42.40 | |||
| Virus. | Flavivirus (PCR). | 101.25 | |||
| Virus. | Hantavirus (PCR) | 101.25 | |||
| Virus. | Hantavirus IgG (ELISA). | 25.90 | |||
|
. |
Hantavirus IgM (ELISA). | 35.00 | |||
| Virus. | HTLV IgG (ELISA) | 35.80 | |||
| Virus. | HTLV IgG (immunoblot). | 163.70 | |||
|
Virus. |
HTLV-I (PCR). | 75,10 | |||
| Virus. | HTLV-II (PCR). | 75,10 | |||
|
Virus. |
Lyssavirus (characterization). | 75.80 | |||
|
. | Lyssavirus (PCR). | 23.00 | |||
|
Norovirus (characterization) |
89,10 | ||||
| Virus. |
Norovirus (RT-PCR). | 57.60 | |||
|
Virus. | Orthopoxvirus (actual PCR-time). | 114.60 | |||
| Virus. | Papillomavirus 16, 18, 31, 33, and 45 (mRNA detection). | 76.30 | |||
| Virus. | High Risk Papillomavirus, VPH16, and VPH18 (actual PCR-time). | 62.70 | |||
| Virus. | cutaneous Papillomavirus (genotyping). |
96.20 | |||
| Virus. | cutaneous Papillomavirus (PCR) | 74.60 |
|||
| Virus. | Mucosal-year-genital Papillomavirus (genotyping-sequencing). | 96.20 | |||
|
Virus. | Papillomavirus mucosal-year-genital (PCR). | 74.60 | |||
|
. | Mucosal-year-genital Papillomavirus (PCR-hybridization). | 90.30 | |||
|
. | Human Parechovirus (real-time PCR). |
53.40 | |||
| Virus. |
18,00 | ||||
| Virus. | Parvovirus-B19 IgM (ELISA). | 21.60 | |||
|
. | Phlevirus (PCR). | 101.25 | |||
|
| 24.90 | ||||
| Prion gene PRPN (PCR-sequencing). | 220,70 | ||||
|
. | Prion protein 14-3-3 (WB). | 154.00 | |||
|
| 89,10 | ||||
| Rotavirus (RT-PCR) |
Virus. |
| 57.60 | ||
|
Virus. | HIV IgG (immunoblot). | 123.70 | |||
|
Virus. |
| 54.60 | |||
| Virus. | HIV-1 (genotyped) | 265.60 | |||
|
. | HIV-1 Proviral DNA (PCR). | 100,70 | |||
| Virus. |
| HIV-1, Integrase antiretroviral (sequencing) resistors. | 119.90 | ||
|
Virus. | HIV-1, PR resistors, and RT (sequencing). | 130,80 | |||
|
Virus. | HIV-1. Tropism and subtype V3 (sequencing). | 105.60 | |||
|
. | HIV-1 Proviral DNA (PCR). |
118.25 | |||
|
. | Chikungunya virus (actual PCR-time). | 106.10 | |||
|
| 206.20 |
. | |||
|
Virus. | Virus. Chikungunya IgG (IFI) | 19.00 | |||
|
. | Chikungunya IgM (IFI) Virus. | 22,70 | |||
|
| 89,10 |
. | Virus. | Virus. IgG (IFI) Lymphocytic Coriomeningitis (IFI) | 10.50 |
|
. | IgM Lymphocytic Coriomenyngitis Virus (IFI) | 14.20 | |||
| Virus. | Crimea-Congo Virus (PCR-actual). | 106,10 | |||
| Virus. | Dengue Virus (PCR-Real Time). | 106.00 | |||
|
. | Virus Dengue Ag-S1 (ELISA). | 88.00 | |||
|
Virus Dengue IgG (ELISA) | 12.50 | ||||
|
Dengue Igm Virus (ELISA). | 24.70 | ||||
|
. | Ebola and Marburg Virus (actual PCR-time). | 270.40 | |||
| Virus. | Encefalitis virus transmitted by IgG ticks (ELISA). | 41.00 | |||
| Virus. | Encefalitis virus transmitted by IgM ticks (ELISA). | 41.00 | |||
| Virus. | Epstein-Barr EA IgG (IFI) Virus. | 17.20 | |||
| Virus. | Virus Epstein-Barr EBNA Ac (ACIF) | 8.10 |
|||
| Virus. | Virus Epstein-Barr Profile IgG (Immunoblot). | 53.00 | |||
| Virus. | Epstein Virus-Barr Profile IgM (immunoblot). | 53.00 | |||
|
. | Virus Epstein-Barr VCA IgG (IFI). | 19.00 | |||
| Virus. | Virus Epstein-Barr VCA IgM (IFI) | 13.00 |
|||
|
Virus. | Exempt Virus (PCR-multiplex). | 21.80 | |||
|
. | Yellow Fever Virus (PCR-Real Time). |
106,10 | |||
|
. | IgG Yellow Fever (IFI) Virus. | 19.00 | |||
|
Virus. | Virus Fever Yellow IgM (IFI) | 22.70 | |||
|
. | Flu Virus (characterization). | 89.75 | |||
| Virus. | Flu Virus (antiviral resistance study). |
76,20 | |||
| . | Virus Flu A (FC). | 10.30 | |||
|
. | Flu Virus A, Ac (IHA). | 35.80 | |||
| Virus. | Virus Flu A, B, C (PCR) | 39.40 | |||
| Virus. | Flu Virus B (FC). | 10,00 | |||
| Virus Flu B, Ac (IHA). | 35.80 | ||||
| Virus. | Virus Hepatitis A (filogeny). | 214.70 | |||
| Virus. | Virus Hepatitis A (IgM + RT-PCR). | 45.50 | |||
| Virus Hepatitis A (RT-PCR). | 32.75 | ||||
| Virus. | Hepatitis B Virus (viral load, real-time PCR). | 67.30 | |||
| Virus. | Virus Hepatitis B (commit) |
114.00 | |||
|
. | Virus Hepatitis B (genotyping). | 37.00 | |||
| Virus Hepatitis B (antiviral resistors) | 37.00 | ||||
| Virus Hepatitis B (region variant S). | 37.00 | ||||
|
. | Hepatitis B Virus (preC and X region variants). | 49.75 | |||
| Virus. | Virus Hepatitis B, filogeny (full sequencing) | 417.20 | |||
| Virus. |
| 174.00 | |||
| Virus Hepatitis C (phylogeny epidemic outbreak). | 214.70 | ||||
|
. | Hepatitis C Virus (genotyping, LIPA). | 154.60 | |||
| Virus. | Virus Hepatitis C (genotyping, sequencing). | 54.00 | |||
| Virus. | Hepatitis C Virus (NS3 protease resistors). | 117.40 | |||
|
Virus Hepatitis C (RT-PCR). | 32.75 | ||||
|
Virus. | Hepatitis C Virus (RT-PCR, viral load). | 66.60 | |||
| Virus. | Virus Hepatitis C IgG (ELISA; avidity). | 23.00 | |||
|
Virus. | Hepatitis C virus; IL28B (actual PCR-time). | 66.70 | |||
| Virus Hepatitis C; ITPA (actual PCR-Time) | 84.90 | ||||
|
. | Hepatitis D Virus (Total Ac + RT-PCR). | 49.75 | |||
| Virus. | Virus Hepatitis D (viral load, PCR to actual time). | 67.30 | |||
|
. | Hepatitis D Virus (RT-PCR). | 32.75 | |||
| Virus Hepatitis E (genotyping, sequencing) | 55,60 | ||||
| Virus Hepatitis E (IgM + IgG + RT-PCR). | 88.00 | ||||
|
. | Hepatitis E Virus (RT-PCR). | 35.40 | |||
| Virus. | Virus Hepatitis E (full sequencing) | 1377.20 | |||
| Virus. | Virus Hepatitis E IgG (immunoblot). | 39.80 | |||
|
. | Virus Hepatitis E IgM (immunoblot). |
||||
|
. | Human Herpes Virus 8 IgG (IFI). | 61.50 | |||
|
Virus. | Virus Herpes Lymphotropes (real time PCR multiplex). | 35.20 | |||
|
. | Herpes Simple Virus (FC). | 10.30 | |||
|
. | Herpes Simple IgG Virus (ELISA). | 15.60 | |||
| Virus. | Virus. |
| 19.20 | ||
| Virus Herpes Simple type-1 and type-2 IgG (immunoblot). | 37.20 | ||||
|
. | Virus identification (microscopy electronic: negative staining) | 29.00 | |||
| Virus. | Identification Virus (electronic microscope:ultramicroomy). | 92.90 | |||
| JC and BK (multiplex real time PCR-PCR-body) | 36.40 | ||||
| Virus. | Virus O ' Nyong Nyong Ac (neutralization). | 206.20 | |||
| Virus. | Virus Parotiditis (genotyped) | 42.40 |
|||
| Virus. | Parotiditis Virus (PCR). | 21.80 | |||
| Virus. | Virus Parotitis IgG (ELISA). | 17.40 | |||
| Virus. | Virus Parotiditis IgM (ELISA). | 19.40 |
|||
| Virus. | Rabia Virus (real-time RT-PCR). | 32.75 | |||
|
Virus Rabia (IFI) Virus. |
| 43.00 | |||
| Virus. | Virus Rabia IgG (ELISA) | 65.30 | |||
| Virus. | Syncytial Respiratory Virus (FC). | 10.30 | |||
| Virus. | Respiratory Virus 1, VRS-MNV-AdV-BoV (PCR). |
44.30 | |||
|
. | Respiratory Virus 2, RIN-EV-VPI-CoV (PCR). | 41.80 | |||
| Virus. | Virus Rubella (genotyped) | 42.40 | |||
| Virus. | Virus Rubella Ac (ELISA; avidity). |
21.60 | |||
|
. | Virus Rubella IgG (ELISA). | 27.70 | |||
|
Virus. | Virus Rubella IgM (ELISA). | 27.70 | |||
|
Virus. | Sarabase_virus (genotyping). | 42.40 | |||
| Virus. | Virus Sargareg IgG (ELISA) | 13.75 |
|||
| Virus. | Sargareg IgM Virus (ELISA). | 27.70 | |||
| Virus. | Tuscany Virus (actual PCR-Time). | 106.10 | |||
| IgG Tuscany Virus (ELISA) | 19.20 | ||||
| Virus. | IgM Tuscany Virus (ELISA). | 18.60 | |||
| Virus. | Virus Varicela Zoster (FC). | 10.30 | |||
| Virus. | Virus Varicela Zoster IgG (ELISA). | 19.20 |
|||
| Virus. | Virus Varicela Zoster IgM (ELISA). | ||||
| West Nile Virus (PCR-Real Time) |
| 106.10 | |||
| Virus West Nile Ac (neutralization). | 206.20 | ||||
|
Virus. | Virus West Nile IgG (ELISA). | 21.00 | |||
| Virus. | West Nile IgM (ELISA) Virus. | 44.10 |
